Table 1.
Patient characteristics of samples included in VA GALT gene expression analysis.
Benign colon disease (n = 9) | Colon AC (n = 9) | PDAC (n = 16) | p-value | |
---|---|---|---|---|
Cancer stage | ||||
Local malignancy | N/A | 6 (66.7%) | 14 (87.5%) | 0.312a |
Metastatic malignancy | 3 (33.3%) | 2 (12.5%) | ||
Age (years; median (range)) | 55.0 (43.0–95.0) | 59.0 (52.0–76.0) | 66.5 (49.0–89.0) | 0.194b |
Sex | ||||
Male | 4 (44.4%) | 3 (33.3%) | 10 (62.5%) | 0.348c |
Female | 5 (55.6%) | 6 (66.7%) | 6 (37.5%) |
VA GALT, vermiform appendix gut-associated lymphoid tissue; n, number; AC, adenocarcinoma; PDAC, pancreatic ductal adenocarcinoma; N/A, not applicable.
aFisher’s exact test.
bWelch ANOVA.
cChi-square test.